Maple Wang

Aaron Diamond AIDS Research Center — United States

Medicine · Health Sciences

18h-index6.3kcitations34works7.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(30), COVID-19 Clinical Research Studies(14), Animal Virus Infections Studies(9), Bacillus and Francisella bacterial research(9), Viral gastroenteritis research and epidemiology(7)

Publications33 total

Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B
Nature Microbiology·2025· 6 citedOpen Access
An Industry Perspective on Understanding of AAV Capsid Content Variants
2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability
Nature Communications·2024· 15 citedOpen Access
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
Science Translational Medicine·2023· 14 citedOpen Access
An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design
Frontiers in Immunology·2023· 4 citedOpen Access
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost
iScience·2023· 6 citedOpen Access
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Cell·2022· 918 citedOpen Access
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
2022· 103 citedOpen Access
Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation
The Lancet Infectious Diseases·2022· 81 citedOpen Access
Antibody avidity and multi-specificity combined to confer protection against SARS-CoV-2 and resilience against viral escape
2022Open Access
Resistance of SARS-CoV-2 Omicron Subvariant BA.4.6 to Antibody Neutralization
2022· 13 citedOpen Access
Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey
mBio·2022· 8 citedOpen Access
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
Nature·2022· 820 citedOpen Access
SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasion
2022· 12 citedOpen Access
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4, and BA.5
2022· 40 citedOpen Access
Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants
Journal of Clinical Virology Plus·2022· 5 citedOpen Access
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses
Science Translational Medicine·2022· 64 citedOpen Access
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Nature·2022· 848 citedOpen Access
Antibody Evasion Properties of SARS-CoV-2 Omicron Sublineages
2022· 128 citedOpen Access
Changes in Serum Neutralizing Antibody Potency and Breadth Post SARS-CoV-2 mRNA Vaccine Boost
SSRN Electronic Journal·2022Open Access
page 1 of 2Next →

Frequent Co-authors

David D. Ho(32), Lihong Liu(27), Yaoxing Huang(25), Yicheng Guo(24), Zizhang Sheng(23), Jian Yu(21), Manoj S. Nair(20), Sho Iketani(19), Michael T. Yin(14), Magdalena E. Sobieszczyk(13), Pengfei Wang(11), Peter D. Kwong(11), Yang Luo(10), Zhiteng Li(10), Lawrence Shapiro(10), Jennifer Y. Chang(9), Jasper Fuk‐Woo Chan(8), Liyuan Liu(7), Yiming Huang(7), Harris H. Wang(7)